iHear MatriX vs Resound Vivia 9 60S microRIE

The iHear MatriX is a budget-priced OTC hearing aid that earns a B grade with a SoundScore of 3.8/5, placing it in the top 40% of the OTC hearing aid category in our lab testing. At $499, this behind-the-ear device delivers solid speech performance that exceeds category averages, though with a notable tradeoff in streaming capabilities. Speech clarity is a clear strength for the MatriX. In quiet environments, it scores 4.0/5—a solid result that sits 1.17 points above the OTC category average. Speech in noise performance is more modest at 2.4/5, which is mixed in absolute terms but still 0.96 points above the typical OTC device. Feedback handling is excellent at 5.0/5, meaning users should experience minimal whistling during daily wear. The most significant limitation is music streaming, which scores 0.0/5—well below the category average of 1.92/5. While the MatriX supports both iPhone and Android streaming, audio fidelity for music is poor in our testing. Own-voice comfort is mixed at 2.7/5, roughly in line with category norms. The MatriX shows meaningful improvement with tuning, jumping from an Initial Score of 3.7/5 to a Tuned Score of 4.2/5. This suggests users who invest time in adjustment can unlock better performance. For budget-conscious buyers prioritizing speech understanding over music quality, the MatriX offers competitive value in its price range, though alternatives like the Elehear Beyond score higher overall at similar pricing.

The ReSound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In our lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #29 of 39 prescription hearing aids tested. This device shows a mixed performance profile. Its standout strength is own-voice comfort, scoring 3.4/5—a solid result that sits 0.70 points above the category average. Speech clarity in quiet environments also performs at category average with a score of 3.4/5. Feedback handling is strong in absolute terms at 4.2/5, though this falls 0.52 points below the category average, reflecting the high bar set by competing prescription devices. The Vivia 9's most notable weakness is speech understanding in noisy environments, where it scored just 1.1/5—a low result that trails the category average by 0.96 points. Music streaming performance is mixed at 2.6/5, sitting slightly below average. These limitations are worth considering given the premium price positioning. For listeners who prioritize comfortable own-voice perception and primarily encounter quieter listening situations, the Vivia 9 may be suitable. However, those frequently in challenging noise environments should note that several alternatives in this price range—including the Phonak Sphere Infinio and Oticon Intent—deliver stronger overall performance in our testing. Budget-conscious shoppers may also find comparable sound quality at lower price points with options like the Jabra Enhance Pro 20 at Costco.